✓Marketing Authorisation Maintained
- Client
- Biotech company
- Service
- Benefit-risk
The challenge
Emerging safety concerns put a high-risk product's benefit-risk profile under regulatory review. The client had to show that therapeutic benefits outweighed the risks.
Our solution
- Collection and analysis of clinical and post-marketing data
- A structured benefit-risk framework
- Stakeholder engagement
- Regulatory submission and follow-up
The results
- Assessment accepted; marketing authorisation kept
- New risk minimisation measures strengthened the safety profile
- Clear communication preserved trust among HCPs and patients
- A proactive benefit-risk process for future products
